Search by Drug Name or NDC
NDC 51672-3007-01 Hydrocortisone and Acetic Acid 20.8; 10.4 mg/mL; mg/mL Details
Hydrocortisone and Acetic Acid 20.8; 10.4 mg/mL; mg/mL
Hydrocortisone and Acetic Acid is a AURICULAR (OTIC) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is ACETIC ACID; HYDROCORTISONE.
Product Information
NDC | 51672-3007 |
---|---|
Product ID | 51672-3007_2f73f2cf-0dc9-4a26-a5b5-9218141245e1 |
Associated GPIs | 87300020102000 |
GCN Sequence Number | 048554 |
GCN Sequence Number Description | hydrocortisone/acetic acid DROPS 1 %-2 % OTIC (EAR) |
HIC3 | Q8B |
HIC3 Description | EAR PREPARATIONS, MISC. ANTI-INFECTIVES |
GCN | 14017 |
HICL Sequence Number | 003594 |
HICL Sequence Number Description | HYDROCORTISONE/ACETIC ACID |
Brand/Generic | Generic |
Proprietary Name | Hydrocortisone and Acetic Acid |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Hydrocortisone and Acetic Acid |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | AURICULAR (OTIC) |
Active Ingredient Strength | 20.8; 10.4 |
Active Ingredient Units | mg/mL; mg/mL |
Substance Name | ACETIC ACID; HYDROCORTISONE |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA088759 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 51672-3007-01 (51672300701)
NDC Package Code | 51672-3007-1 |
---|---|
Billing NDC | 51672300701 |
Package | 1 BOTTLE in 1 CARTON (51672-3007-1) / 10 mL in 1 BOTTLE |
Marketing Start Date | 2005-04-28 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 9.03545 |
Pricing Unit | ML |
Effective Date | 2024-02-21 |
NDC Description | HYDROCORTISON-ACETIC ACID SOLN |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 6383c722-84e2-4719-a13d-19c54e3eefff Details
DESCRIPTION
Hydrocortisone and Acetic Acid Otic Solution, USP contains Hydrocortisone (1%) and acetic acid, glacial (2%) in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.2%), propylene glycol diacetate (3%) and sodium acetate (0.015%).
Acetic acid has a molecular formula of CH3COOH with molecular weight of 60.05. The structural formula is:

Acetic Acid
Hydrocortisone is a Synthetic Steroid used as an anti-inflammatory and antipruritic agent. Its chemical name is Pregn-4-ene-3,20-dione, 11, 17, 21-trihydroxy-, (11β)-. Hydrocortisone has a molecular formula of C21H30O5 with molecular weight 362.46. The structural formula is:

Hydrocortisone
Hydrocortisone and acetic acid is available as a non-aqueous otic solution buffered at pH (2.0 to 4.0) for use in the external ear canal.
CLINICAL PHARMACOLOGY
INDICATIONS AND USAGE
CONTRAINDICATIONS
PRECAUTIONS
ADVERSE REACTIONS
DOSAGE AND ADMINISTRATION
Carefully remove all cerumen and debris to allow hydrocortisone 1% and acetic acid 2% otic solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with the solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of the solution every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.
HOW SUPPLIED
SPL UNCLASSIFIED SECTION
PRINCIPAL DISPLAY PANEL - 10 mL Bottle Carton
INGREDIENTS AND APPEARANCE
HYDROCORTISONE AND ACETIC ACID
hydrocortisone and acetic acid solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(51672-3007) |